Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706784 · ClinicalTrials.gov registry record · Phase 1
Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00706784: Clinical Trial Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00706784 is a Phase 1 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00706784, a Phase 1 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This research study is looking at how well a new drug delivery system, called the vaginal ring, works to get hormones into your body as a form of birth control.
Interventions
- DRUG Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-06 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Why NCT00706784 stopped before completion
NCT00706784 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System is the first listed.
NCT00706784 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00706784 about?
NCT00706784 is a clinical study titled "Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study". This research study is looking at how well a new drug delivery system, called the vaginal ring, works to get hormones into your body as a form of birth control.
What is the current status of trial NCT00706784?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2008-06. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00706784?
The interventions under investigation include: Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System (DRUG).
Who is sponsoring clinical trial NCT00706784?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00706784's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia